.Merck defeats incomes assumptions, increases purchases expectation on sturdy demand for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Income Projections as Keytruda Sales Increase BloombergMerck Inventory: Pharma Titan Posts Strong Outcomes, But Overview Tumbles Short Capitalist's Business DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats profit as well as purchases desires in the middle of Keytruda strength, however supplies blended full-year outlook MarketWatch.